Provided by Tiger Fintech (Singapore) Pte. Ltd.

BioNTech SE

115.64
+2.542.25%
Pre-market: 117.161.52+1.31%05:43 EDT
Volume:3.22M
Turnover:381.51M
Market Cap:27.80B
PE:-33.54
High:122.90
Open:121.00
Low:115.38
Close:113.10
Loading ...

U.S.-Listed Shares of BioNTech up 7.5% After 18% Advance in Previous Session, Brokerages Raise PT

THOMSON REUTERS
·
Yesterday

U.S.-Listed Shares of BioNTech up 10% Premarket After 18% Advance in Previous Session, Brokerages Raise PT

THOMSON REUTERS
·
Yesterday

Trump's Tax Bill Is Testing the Dollar. This Red Flag Matters More. -- Barrons.com

Dow Jones
·
Yesterday

Stock Track | BioNTech Soars 5.15% Pre-Market on $11.1 Billion Cancer Drug Deal with Bristol Myers Squibb

Stock Track
·
Yesterday

Health Ministry debunks COVID-19 misinformation on autopsy, vaccination laws

CNA
·
Yesterday

BioNTech Se : Jefferies Raises Target Price to $151 From $149

THOMSON REUTERS
·
Yesterday

BioNTech Jumps Another 3.7% After Surging 18% as Bristol-Myers to Pay BioNTech Up to $11.1 Billion in Cancer Deal

Tiger Newspress
·
Yesterday

Post-Bell | U.S. Stocks Close Higher; Tesla Drops 1%; Nvidia Gains 2%; Cleveland-Cliffs Surges 23%; Applied Digital Soars 48%

Tiger Newspress
·
Yesterday

Sector Update: Health Care Stocks End Higher Late Afternoon

MT Newswires Live
·
Yesterday

BioNTech SE ADR Rises 18.0%, Outperforms Market

Dow Jones
·
Yesterday

BNT327 deal bolsters BioNTech’s competitive position, says Leerink

TIPRANKS
·
Yesterday

Truist Securities Adjusts BioNTech Price Target to $155 From $151, Maintains Buy Rating; Shares Jump

MT Newswires Live
·
Yesterday

BioNTech price target raised to $155 from $151 at Truist

TIPRANKS
·
Yesterday

Clear Street Remains a Buy on BioNTech SE (BNTX)

TIPRANKS
·
Yesterday

Bristol deal takes out ‘key’ potential buyer of Summit Therapeutics, says Truist

TIPRANKS
·
Yesterday

UBS Keeps Their Hold Rating on BioNTech SE (BNTX)

TIPRANKS
·
Yesterday

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

MT Newswires Live
·
02 Jun

BioNTech Up Nearly 17%, on Pace for Largest Percent Increase Since September 2024 -- Data Talk

Dow Jones
·
02 Jun

BioNTech Rockets 17% as Bristol-Myers to Pay BioNTech Up to $11.1 Billion in Cancer Deal

Bloomberg
·
02 Jun

Stock Track | BioNTech Soars 15.38% on $11.1 Billion Cancer Drug Partnership with Bristol Myers Squibb

Stock Track
·
02 Jun